Osteopontin at the crossroads of inflammation and tumor progression

LM Castello, D Raineri, L Salmi… - Mediators of …, 2017 - Wiley Online Library
Complex interactions between tumor and host cells regulate systemic tumor dissemination,
a process that begins early at the primary tumor site and goes on until tumor cells detach …

The extracellular matrix: A key player in the pathogenesis of hematologic malignancies

I Sidhu, SP Barwe, A Gopalakrishnapillai - Blood Reviews, 2021 - Elsevier
Hematopoietic stem and progenitor cells located in the bone marrow lay the foundation for
multiple lineages of mature hematologic cells. Bone marrow niches are architecturally …

Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count

YL Li, ZH Shi, X Wang, KS Gu, ZM Zhai - BMC cancer, 2019 - Springer
Background Diffuse large B-cell lymphoma (DLBCL) is characterized by its clinical and
biological heterogeneity. The clinical prognostic implications of tumor-associated …

Osteopontin and their roles in hematological malignancies: Splice variants on the new avenues

ACSF Bastos, CB Blunck, M Emerenciano - Cancer letters, 2017 - Elsevier
Osteopontin (OPN) is a protein expressed in several tissues, including bone marrow, in
which it performs distinct roles, such as modulating hematopoietic stem cell niche and bone …

Preliminary Study of the Relationship between Osteopontin and Relapsed Hodgkin's Lymphoma

V De Re, E Lopci, G Brisotto, C Elia, L Mussolin… - Biomedicines, 2023 - mdpi.com
The primary objective of this study was to investigate the potential role of tissue osteopontin,
also known as secreted phosphoprotein 1 (SPP1), as a contributing factor to an unfavorable …

[HTML][HTML] Biomarcadores serológicos de riesgo en linfoma no Hodgkin

LS Sosa-Quintero, SG Barreno-Rocha… - Salud …, 2023 - medigraphic.com
Los linfomas pertenecen a un grupo de neoplasias que se originan de la proliferación
maligna de los linfocitos. Globocan reporta que, en México, el linfoma no Hodgkin (LNH) …

Serologic biomarkers of risk in non-Hodgkins lymphoma

LS Sosa-Quintero, SG Barreno-Rocha… - Salud …, 2023 - medigraphic.com
Lymphomas belong to a group of neoplasms that originate from the malignant proliferation
of lymphocytes. Globocan reports that in Mexico, Non-Hodgkin's lymphoma (NHL) occupies …

[HTML][HTML] 肿瘤相关巨噬细胞对弥漫大B 细胞淋巴瘤预后影响机制的研究进展

黄伟民, 魏永强, 冯茹 - Chinese Journal of Hematology, 2018 - ncbi.nlm.nih.gov
弥漫大B 细胞淋巴瘤(diffues large B-cell lymphoma, DLBCL) 为最常见的非霍奇金淋巴瘤,
是一组在遗传学, 病理特征, 免疫表型和临床表现及治疗反应均具有高度异质性的恶性肿瘤[1-2] …

Biology of Tumor Associated Macrophages in Diffuse Large B Cell Lymphoma

W Huang, X Wei, Y Wei, R Feng - DNA and Cell Biology, 2018 - liebertpub.com
The tumor associated microenvironment is known to play a vital role during the development
and progression of different malignant tumors. As a part of tumor microenvironment, tumor …

Angiogenesis and osteopontin expression in paraskeletal myeloma with plasmablastic morphology and aggressive clinical course: a report of two cases

T Valković, MS Damić, F Valković… - Journal of Cancer …, 2022 - unirepository.svkri.uniri.hr
Extramedullary disease (EMD) of multiple myeloma (MM) can present as paraskeletal
(paraosseous) plasmocytoma (PP) that arise from skeletal focal lesions or extramedullary …